Synthesis of peptide fragments spike glycoprotein SARS-CoV-2 and studying their binding with human blood cells

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A new method was tested that allows to evaluate activation of the Spike surface protein of SARS-CoV-2 blood leukocytes by synthetic peptides, fragments Lys-Ile-Ala-Asp-Tyr-Asn-Tyr-Lys-Leu (417–425 аа) and Val-Arg-Gln-Ala-Pro-Asn-Gly-Gln-Thr (407–415 аа). It was found that these peptides, regardless of the HLA-A phenotype of the subjects, could bind to leukocytes, which indicates the universality of reactions to peptides, especially in innate immune cells. It was shown that the Lys-Ile-Ala-Asp-Tyr-Asn-Tyr-Lys-Leu peptide contacted the blood leukocytes of the subjects, activated the lymphocytes and basophils of the subjects (statistically significant), which was confirmed by an increase in gamma interferon compared to the Val-Arg-Gln-Ala-Pro-Asn-Gly-Gln-Thr. Thus, this work demonstrates an approach to creating a new peptide vaccine against COVID-19 at the stage of in vitro research.

全文:

受限制的访问

作者简介

О. Gribovskaya

Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus

编辑信件的主要联系方式.
Email: olymelnik@yandex.ru
白俄罗斯, ul. Akad. Kuprevicha 5/2, Minsk, 220084

V. Yanchenko

Vitebsk State medical University

Email: olymelnik@yandex.ru
白俄罗斯, pr. Frunze 27, Vitebsk, 210023

A. Tsygankov

Vitebsk State medical University

Email: olymelnik@yandex.ru
俄罗斯联邦, pr. Frunze 27, Vitebsk, 210023

V. Martinovich

Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus

Email: olymelnik@yandex.ru
俄罗斯联邦, ul. Akad. Kuprevicha 5/2, Minsk, 220084

参考

  1. Mathieu E., Ritchie H., Ortiz-Ospina E., Roser M., Hasell J., Appel C., Giattino Ch., Rodés-Guirao L. // Nat. Hum. Behav. 2021. V. 5. P. 947–953. https://doi.org/10.1038/s41562-021-01122-8
  2. Pollard A.J., Bijker E.M. // Nat. Rev. Immunology. 2021. V. 21. P. 83–100. https://doi.org/10.1038/s41577-020-00479-7
  3. Park J.H., Lee H.K. // Vaccines. 2021. V. 9. P. 524–539. https://doi.org/10.3390/vaccines9050524
  4. Yang H., Cao J., Lin X., Yue J., Zieneldien T., Kim J., Wang L., Fang J., Huang R.-P., Bai Yu., Sneed K., Cao Ch. // Viruses. 2022. V. 14. P. 449–463. https://doi.org/10.3390/v14030449
  5. Heidary M., Kariar V.H., Shirani M., Ghanavati R., Motahar M., Sholeh M., Ghahramanpour H., Khoshnood S. // Front. Microbiol. 2022. V. 13. P. 927306–927306. https://doi.org/10.3389/fmicb.2022.927306
  6. Chiplunkar S., Baravkar A., Paricharak S., Masal A., Aher N. // J. Young. Pharm. 2022. V. 14. P. 133–139.
  7. Triccas J.A., Kint J., Wurm F.M. // NPJ Vaccines. 2022. V. 7. P. 1–2. https://doi.org/10.1038/s41541-022-00507-8
  8. Hanan N., Doud R.L., Jr., Park In-W., Jones H.P., Mathew S.O. // Vaccines. 2021. V. 9. P. 596–613. https://doi.org/10.3390/vaccines9060596
  9. Крит Н.А., Филатова Н.П., Ковальчук О.В., Бесчастная Н.В. // Биоорг. химия. 1981. Т. 7. С. 965–970.
  10. Hermiston M.L., Xu Z., Weiss A. // Annu. Rev. Immunol. 2003. V. 21. P. 107–137. https://doi.org/10.1146/annurev.immunol.21.120601.140946
  11. Sancho D., Gomez M., Sanchez-Madrid F. // Trends Immunol. 2005. V. 26. P. 136–140. https://doi.org/10.1016/j.it.2004.12.006
  12. Gorelik A., Randriamihaja A., Illes K., Nagar B. // FEBS J. 2018. V. 285. P. 2481–2494. https://doi.org/10.1111/febs.14489
  13. Pols M.S., Klumperman J. // Exp. Cell Res. 2009. V. 315. P. 1584–1592. https://doi.org/10.1016/j.yexcr.2008.09.020
  14. Murugesan K., Jagannathan P., Pham Th.D., Pandey S., Bonilla H.F., Jacobson K., Parsonnet J., Andrews J.R., Weiskopf D., Sette A., Pinsky B.A., Singh U., Banaei N. // Clin. Infect. Dis. 2021. V. 73. P. 3130–3132. https://doi.org/doi: 10.1093/cid/ciaa1537
  15. Aiello A., Coppola A., Vanini V., Petrone L., Cuzzi G., Salmi A., Altera A.M.G., Tortorella C., Gualano G., Gasperini C., Scolieri P., Beccacece A., Vita S., Bruzzese V., Lorenzetti R., Palmieri F., Nicastri E., Goletti D. // Int. J. Infect. Dis. 2022. V. 122. P. 841– 849. https://doi.org/10.1016/j.ijid.2022.07.049
  16. Todorovic-Rakovic N., Whitfield J.R. // Cytokine. 2021. V. 146. P. 1537–1556. https://doi.org/10.1016/j.cyto.2021.155637

补充文件

附件文件
动作
1. JATS XML
下载
2. Scheme 1. Synthesis of peptide (IX).

下载 (195KB)
索引源数据
3. Scheme 2. Synthesis of peptide (XVIII).

下载 (156KB)
索引源数据

版权所有 © Russian Academy of Sciences, 2024